http://rdf.ncbi.nlm.nih.gov/pubchem/reference/35202850

Outgoing Links

Predicate Object
contentType Clinical Trial, Phase II|Journal Article|Multicenter Study
issn 1536-5964
issueIdentifier 37
pageRange e30345-
publicationName Medicine
startingPage e30345
bibliographicCitation Hwang S, Lee BH, Kim WS, Kim DS, Cheon CK, Lee CH, Choi Y, Choi JH, Kim JH, Yoo HW. A phase II, multicenter, open-label trial to evaluate the safety and efficacy of ISU303 (Agalsidase beta) in patients with Fabry disease. Medicine (Baltimore). 2022 Sep 16;101(37):e30345. PMID: 36123934; PMCID: PMC9478233.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_156853a22ae53f2046d7e7fc95b9f048
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7265b95684ef7a19af2854e5a1ece1d0
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_353e25435862b2d512994d25619729ab
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a5fd43698b900a48092bf8aadbf731a7
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c5eefbd857c95120f2a47ccb5bc23f47
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0fb556ed20b5f7aca50bb8a5d161ce0b
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_da465386a766562dc4ab3775a2cc19a5
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b45996727dad0488d38ae81bae689e11
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d15715b00a69a2945ac2f839035b75ea
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1fc657a85d1ae001d0e97e2db4809062
date 2022-09-16^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://pubmed.ncbi.nlm.nih.gov/36123934
https://doi.org/10.1097/md.0000000000030345
https://pubmed.ncbi.nlm.nih.gov/PMC9478233
isPartOf https://portal.issn.org/resource/ISSN/1536-5964
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/5748
language English
source https://pubmed.ncbi.nlm.nih.gov/
https://www.crossref.org/
title A phase II, multicenter, open-label trial to evaluate the safety and efficacy of ISU303 (Agalsidase beta) in patients with Fabry disease
discusses http://id.nlm.nih.gov/mesh/M0000793
http://id.nlm.nih.gov/mesh/M0430431
http://id.nlm.nih.gov/mesh/M0011758
hasPrimarySubjectTerm http://id.nlm.nih.gov/mesh/D000795Q000175
http://id.nlm.nih.gov/mesh/D000519Q000627
http://id.nlm.nih.gov/mesh/D000795Q000188
hasSubjectTerm http://id.nlm.nih.gov/mesh/D005260
http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D008297
http://id.nlm.nih.gov/mesh/D010146Q000188
http://id.nlm.nih.gov/mesh/D007527
http://id.nlm.nih.gov/mesh/D011788
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/protein/EC_3.2.1.22
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8756
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_78ded0e9bfc02dc0b4484fe076924aab
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6900
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6449939
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID66616222

Showing number of triples: 1 to 45 of 45.